The patient journey with vaginal atrophy
Patients need your help to start the conversation
Women will need to understand their condition, but may prefer the discussion to be started by their healthcare professional.1
Enabling early treatment can benefit patients
Early diagnosis and treatment of vaginal atrophy can allow you to interrupt the progressive changes that impact women’s quality of life.2-4
Patients need your help to start the conversation
Women will need to understand their condition, but may prefer the discussion to be started by their healthcare professional.1
You might need to start the conversation
Early diagnosis and treatment of vaginal atrophy can allow you to interrupt the progressive changes that impact women’s quality of life.2-4
My Blissel® Time to talk
Video Library
A library of discussions led by national experts Dr Anne Connolly, Dr Diana Mansour and Nurse Specialist Consultant Nikki Noble.
The videos cover a range of very useful, relevant and important topics including, the signs and symptoms of VA, how to make the diagnosis and the impact of vaginal atrophy on a patients quality of life.
The diagnosis of vaginal atrophy is not always straightforward
For women, the diagnosis can be complicated by the multiple symptoms of vaginal atrophy, including:5
- Pain during sex or on passing urine
- Vaginal dryness
- Itching
- Burning
For women, the diagnosis can be complicated by the multiple symptoms of vaginal atrophy, including:5
- Pain during sex or on passing urine
- Vaginal dryness
- Itching
- Burning
Prescribe Blissel® by brand for your patients.
Blissel® is the first and only prescribable estriol containing gel for the treatment of vaginal atrophy6,7
Patients have difficulty discussing their condition
For reasons that are understandable, women may hesitate when discussing vaginal symptoms.8
Whilst there can be many motivations, they can commonly include embarrassment, feeling the discussion is inappropriate, or that nothing can be done.8
Blissel®treats the bothersome symptoms of vaginal atrophy
Blissel® is an ultra low dose estriol vaginal gel containing 50 micrograms per dose (1 gram) of estriol, indicated for treating the symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women.6,7
Upcoming Webinars 2024
30th Sept
7pm to
9pm
Prescribing Precision – Medications for symptom relief with Dr Diana Mansour
- Join us for an informative discussion about prescribing medications for Vaginal Atrophy symptom relief.
To register your interest please click below:
How BlisselⓇ
Works
Efficacy
Dosing
Ultra low dose estriol vaginal gel6,7
Prescribing and Adverse event reporting information for BlisselⓇ can be found here.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Consilient Health (UK) Ltd, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com
- Krychman M, et al. J Sex Med 2017;14:425-433.
- Moral E, et al. Menopause. 2018;25(12):1418-23.
- Cagnacci A, et al. Climacteric. 2019;22(1):85-89.
- NAMS position statement. Menopause. 2020;27(9):976-92.
- Palmaa F, et al. Maturitas. 2018;108:18–23.
- Blissel 50 micrograms/g vaginal gel. Summary of product characteristics.
- Cano A, et al. Menopause. 2012;19(10):1130-9.
- Kagan R, et al. Drugs Aging. 2019;36:897–908.
Date of preparation: Aug 2024 | UK-BLS-531